172 related articles for article (PubMed ID: 28924001)
21. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
[TBL] [Abstract][Full Text] [Related]
22. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
[TBL] [Abstract][Full Text] [Related]
23. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
Taschner PE; Bröcker-Vriends AH; van der Mey AG
Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
[TBL] [Abstract][Full Text] [Related]
24. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
Rusyn L; Kohn B
Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
[No Abstract] [Full Text] [Related]
25. [Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma].
Broudin C; Favier J; Verkarre V; Méatchi T
Ann Pathol; 2020 Apr; 40(2):134-141. PubMed ID: 32146049
[TBL] [Abstract][Full Text] [Related]
26. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
[TBL] [Abstract][Full Text] [Related]
27. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
[TBL] [Abstract][Full Text] [Related]
28. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
32. Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
Fischer A; Kloos S; Maccio U; Friemel J; Remde H; Fassnacht M; Pamporaki C; Eisenhofer G; Timmers HJLM; Robledo M; Fliedner SMJ; Wang K; Maurer J; Reul A; Zitzmann K; Bechmann N; Žygienė G; Richter S; Hantel C; Vetter D; Lehmann K; Mohr H; Pellegata NS; Ullrich M; Pietzsch J; Ziegler CG; Bornstein SR; Kroiss M; Reincke M; Pacak K; Grossman AB; Beuschlein F; Nölting S
J Clin Endocrinol Metab; 2023 Sep; 108(10):2676-2685. PubMed ID: 36946182
[TBL] [Abstract][Full Text] [Related]
33. Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
Xekouki P; Stratakis CA
Endocr Relat Cancer; 2012 Dec; 19(6):C33-40. PubMed ID: 22889736
[TBL] [Abstract][Full Text] [Related]
34. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
35. A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.
Yamanaka M; Shiga K; Fujiwara S; Mizuguchi Y; Yasuda S; Ishizawa K; Saiki Y; Higashi K; Ogawa T; Kimura N; Horii A
Tohoku J Exp Med; 2018 Jun; 245(2):99-105. PubMed ID: 29925701
[TBL] [Abstract][Full Text] [Related]
36. Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.
Vicha A; Taieb D; Pacak K
Endocr Relat Cancer; 2014 Jun; 21(3):R261-77. PubMed ID: 24500761
[TBL] [Abstract][Full Text] [Related]
37. Germinal defects of SDHx genes in patients with isolated pituitary adenoma.
Mougel G; Lagarde A; Albarel F; Essamet W; Luigi P; Mouly C; Vialon M; Cuny T; Castinetti F; Saveanu A; Brue T; Barlier A; Romanet P
Eur J Endocrinol; 2020 Oct; 183(4):369-379. PubMed ID: 32621582
[TBL] [Abstract][Full Text] [Related]
38. A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma.
Jiang Q; Zhang Y; Zhou YH; Hou YY; Wang JY; Li JL; Li M; Tong HX; Lu WQ
Int J Clin Exp Pathol; 2015; 8(10):12188-97. PubMed ID: 26722403
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
40. SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma.
Perez K; Jacene H; Hornick JL; Ma C; Vaz N; Brais LK; Alexander H; Baddoo W; Astone K; Esplin ED; Garcia J; Halperin DM; Kulke MH; Chan JA
Endocr Relat Cancer; 2022 Sep; 29(9):533-544. PubMed ID: 35731023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
